Geneos Wealth Management’s Abacus FCF Innovation Leaders ETF ABOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,324
| Closed | -$177K | – | 2548 |
|
|
2026
Q1 | $177K | Hold |
5,324
| – | – | ﹤0.01% | 996 |
|
|
2025
Q4 | $208K | Hold |
5,324
| – | – | 0.01% | 912 |
|
|
2025
Q3 | $216K | Hold |
5,324
| – | – | 0.01% | 875 |
|
|
2025
Q2 | $206K | Sell |
5,324
-2,662
| -33% | -$94.8K | 0.01% | 981 |
|
|
2025
Q1 | $272K | Buy |
7,986
+5,324
| +200% | +$194K | ﹤0.01% | 1109 |
|
|
2024
Q4 | $96.4K | Sell |
2,662
-20,351
| -88% | -$730K | ﹤0.01% | 1082 |
|
|
2024
Q3 | $773K | Sell |
23,013
-960
| -4% | -$30.6K | 0.03% | 457 |
|
|
2024
Q2 | $757K | Buy |
23,973
+339
| +1% | +$10.2K | 0.03% | 408 |
|
|
2024
Q1 | $720K | Sell |
23,634
-714
| -3% | -$21K | 0.03% | 412 |
|
|
2023
Q4 | $676K | Sell |
24,348
-3,627
| -13% | -$94K | 0.03% | 409 |
|
|
2023
Q3 | $695K | Buy |
27,975
+942
| +3% | +$24.1K | 0.04% | 393 |
|
|
2023
Q2 | $684K | Sell |
27,033
-12,678
| -32% | -$300K | 0.04% | 394 |
|
|
2023
Q1 | $932K | Sell |
39,711
-3,147
| -7% | -$71.9K | 0.06% | 303 |
|
|
2022
Q4 | $945K | Sell |
42,858
-8,649
| -17% | -$194K | 0.06% | 284 |
|
|
2022
Q3 | $1.12M | Buy |
51,507
+138
| +0.3% | +$3.21K | 0.08% | 236 |
|
|
2022
Q2 | $1.15M | Sell |
51,369
-126
| -0.2% | -$2.98K | 0.06% | 291 |
|
|
2022
Q1 | $1.38M | Buy |
51,495
+5,607
| +12% | +$147K | 0.06% | 279 |
|
|
2021
Q4 | $1.35M | Sell |
45,888
-866
| -2% | -$26.1K | 0.05% | 321 |
|
|
2021
Q3 | $1.36M | Sell |
46,754
-2,077
| -4% | -$61.7K | 0.05% | 314 |
|
|
2021
Q2 | $1.41M | Buy |
48,831
+2,034
| +4% | +$55.9K | 0.06% | 290 |
|
|
2021
Q1 | $1.28M | Sell |
46,797
-2,466
| -5% | -$65.8K | 0.04% | 364 |
|
|
2020
Q4 | $1.29M | Buy |
+49,263
| New | +$1.26M | 0.05% | 294 |
|
Geneos Wealth Management's ABOT Position: Q2 2026 in Review
Geneos Wealth Management sold out of Abacus FCF Innovation Leaders ETF (ABOT) in Q2 2026, closing a stake of 5,324 shares — an estimated $177K sold.
Geneos Wealth Management first reported a position in ABOT in Q4 2020 and held it in 22 quarters. The position peaked at $1.41M in Q2 2021. 0 funds tracked by Wall St. Rank hold ABOT as of Q2 2026.
- Geneos Wealth Management reported no remaining Abacus FCF Innovation Leaders ETF position as of Q2 2026 after selling out during the quarter.
- Geneos Wealth Management sold 5,324 Abacus FCF Innovation Leaders ETF shares in Q2 2026, an estimated $177K.
- Geneos Wealth Management first reported a position in Abacus FCF Innovation Leaders ETF in Q4 2020 and held it in 22 quarters.
- Geneos Wealth Management's Abacus FCF Innovation Leaders ETF position peaked at $1.41M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Abacus FCF Innovation Leaders ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.